Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?

References

• BaigentCBlackwellLEmbersonJEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet20103761670168121067804
   PubMed Web of Science ®Google Scholar
• LibbyPThe forgotten majority: unfinished business in cardiovascular risk reductionJ Am Coll Cardiol2005461225122816198835
   PubMed Web of Science ®Google Scholar
• RobinsonJGWangSSmithBJJacobsonTAMeta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease riskJ Am Coll Cardiol20095331632219161879
   PubMed Web of Science ®Google Scholar
• AscasoJFMillanJMateo-GallegoRPrevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic populationEur J Intern Med20112217718121402249
   PubMed Web of Science ®Google Scholar
• ChristianJBBourgeoisNSnipesRLoweKAPrevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adultsAm J Cardiol201110789189721247544
   PubMed Web of Science ®Google Scholar
• AustinMAHokansonJEEdwardsKLHypertriglyceridemia as a cardiovascular risk factorAm J Cardiol1998817B12B9462597
   PubMed Web of Science ®Google Scholar
• BansalSBuringJERifaiNMoraSSacksFMRidkerPMFasting compared with nonfasting triglycerides and risk of cardiovascular events in womenJAMA200729830931617635891
   PubMed Web of Science ®Google Scholar
• GuerinMLe GoffWLasselTSVan TolASteinerGChapmanMJAtherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemiaArterioscler Thromb Vasc Biol20012128228811156866
   PubMed Web of Science ®Google Scholar
• ProctorSDVineDFMamoJCArterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopyArterioscler Thromb Vasc Biol2004242162216715345509
   PubMed Web of Science ®Google Scholar
• NordestgaardBGWoottonRLewisBSelective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner mediaArterioscler Thromb Vasc Biol1995155345427749867
   PubMed Web of Science ®Google Scholar
• TanakaAAiMKobayashiYTamuraMShimokadoKNumanoFMetabolism of triglyceride-rich lipoproteins and their role in atherosclerosisAnn N Y Acad Sci200194720721211795268
   PubMed Web of Science ®Google Scholar
• NordestgaardBGNielsenLBAtherosclerosis and arterial influx of lipoproteinsCurr Opin Lipidol199452522577981955
   PubMedGoogle Scholar
• WangCSMcConathyWJKloerHUAlaupovicPModulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-IIIJ Clin Invest1985753843903973011
   PubMed Web of Science ®Google Scholar
• BobikAApolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolismCirculation200811870270418695202
   PubMed Web of Science ®Google Scholar
• ThomsenMVarboATybjaerg-HansenANordestgaardBGLow nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization studyClin Chem20146073774624436475
   PubMed Web of Science ®Google Scholar
• VarboABennMTybjaerg-HansenANordestgaardBGElevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammationCirculation20131281298130923926208
   PubMed Web of Science ®Google Scholar
• ZhengCUpdates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular diseaseCurr Opin Lipidol201425353924345989
   PubMed Web of Science ®Google Scholar
• JalkanenLThe effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health careScand J Soc Med19911966711925430
   PubMedGoogle Scholar
• KraussRMBlanchePJRawlingsRSFernstromHSWilliamsPTSeparate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemiaAm J Clin Nutr2006831025103116685042
   PubMed Web of Science ®Google Scholar
• GardnerCDKiazandAAlhassanSComparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trialJAMA200729796997717341711
   PubMed Web of Science ®Google Scholar
• PurnellJQKahnSEAlbersJJNevinDNBrunzellJDSchwartzRSEffect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older menJ Clin Endocrinol Metab20008597798210720026
   PubMed Web of Science ®Google Scholar
• CaoYMaugerDTPelkmanCLZhaoGTownsendSMKris-EthertonPMEffects of moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a meta-analysis of clinical trials in subjects with and without diabetesJ Clin Lipidol20093193221291785
   PubMed Web of Science ®Google Scholar
• SevastianovaKSantosAKotronenAEffect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humansAm J Clin Nutr20129672773422952180
   PubMed Web of Science ®Google Scholar
• WesterbackaJKotronenAFieldingBASplanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver diseaseGastroenterology201013919611971. e120600015
   PubMed Web of Science ®Google Scholar
• VolekJSSharmanMJForsytheCEModification of lipoproteins by very low-carbohydrate dietsJ Nutr20051351339134215930434
   PubMed Web of Science ®Google Scholar
• ShaiISchwarzfuchsDHenkinYWeight loss with a low-carbohydrate, Mediterranean, or low-fat dietN Engl J Med200835922924118635428
   PubMed Web of Science ®Google Scholar
• SeipRLMairKColeTGSemenkovichCFInduction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transientAm J Physiol1997272E255E2619124332
   PubMed Web of Science ®Google Scholar
• CarrollSDudfieldMWhat is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndromeSports Med20043437141815157122
   PubMed Web of Science ®Google Scholar
• EliassonBMeroNTaskinenMRSmithUThe insulin resistance syndrome and postprandial lipid intolerance in smokersAtherosclerosis199712979889069521
   PubMed Web of Science ®Google Scholar
• BrintonEAEffects of ethanol intake on lipoproteins and atherosclerosisCurr Opin Lipidol20102134635120616714
   PubMed Web of Science ®Google Scholar
• Bakker-ArkemaRGDavidsonMHGoldsteinRJEfficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaJAMA19962751281338531308
   PubMed Web of Science ®Google Scholar
• SteinEALaneMLaskarzewskiPComparison of statins in hypertriglyceridemiaAm J Cardiol19988166B69B
   PubMed Web of Science ®Google Scholar
• StaelsBDallongevilleJAuwerxJSchoonjansKLeitersdorfEFruchartJCMechanism of action of fibrates on lipid and lipoprotein metabolismCirculation199898208820939808609
   PubMed Web of Science ®Google Scholar
• FrickMHSyvanneMNieminenMSPrevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupCirculation199796213721439337181
   PubMed Web of Science ®Google Scholar
• No authors listedEffect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised studyLancet200135790591011289345
   PubMed Web of Science ®Google Scholar
• ManninenVEloMOFrickMHLipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA19882606416513164788
   PubMed Web of Science ®Google Scholar
• RubinsHBRobinsSJCollinsDGemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study GroupN Engl J Med199934141041810438259
   PubMed Web of Science ®Google Scholar
• GinsbergHNElamMBLovatoLCEffects of combination lipid therapy in type 2 diabetes mellitusN Engl J Med20103621563157420228404
   PubMed Web of Science ®Google Scholar
• KeechASimesRJBarterPEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet20053661849186116310551
   PubMed Web of Science ®Google Scholar
• TonkinAHuntDVoyseyMEffects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAm Heart J201216350851422424024
   PubMed Web of Science ®Google Scholar
• KeechACMitchellPSummanenPAEffect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialLancet20073701687169717988728
   PubMed Web of Science ®Google Scholar
• JunMFooteCLvJEffects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisLancet20103751875188420462635
   PubMed Web of Science ®Google Scholar
• NissenSENichollsSJWolskiKEffects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trialsJAMA20072971362137317384435
   PubMed Web of Science ®Google Scholar
• LincoffAMTardifJCSchwartzGGEffect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trialJAMA20143111515152524682069
   PubMed Web of Science ®Google Scholar
• CarlsonLAHamstenAAsplundAPronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acidJ Intern Med19892262712762530298
   PubMed Web of Science ®Google Scholar
• GanjiSHTavintharanSZhuDXingYKamannaVSKashyapMLNiacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cellsJ Lipid Res2004451835184515258194
   PubMed Web of Science ®Google Scholar
• No authors listedClofibrate and niacin in coronary heart diseaseJAMA19752313603811088963
   PubMed Web of Science ®Google Scholar
• CarlsonLARosenhamerGReduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acidActa Med Scand19882234054183287837
   PubMed Web of Science ®Google Scholar
• BrownBGZhaoXQChaitASimvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary diseaseN Engl J Med20013451583159211757504
   PubMed Web of Science ®Google Scholar
• TaylorAJSullenbergerLELeeHJLeeJKGraceKAArterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statinsCirculation20041103512351715537681
   PubMed Web of Science ®Google Scholar
• TaylorAJLeeHJSullenbergerLEThe effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3Curr Med Res Opin2006222243225017076985
   PubMed Web of Science ®Google Scholar
• SibleyCTVavereALGottliebIMRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque studyHeart2013991675168023872591
   PubMed Web of Science ®Google Scholar
• BodenWEProbstfieldJLAndersonTNiacin in patients with low HDL cholesterol levels receiving intensive statin therapyN Engl J Med20113652255226722085343
   PubMed Web of Science ®Google Scholar
• LandrayMJHaynesRHopewellJCEffects of extended-release niacin with laropiprant in high-risk patientsN Engl J Med201437120321225014686
   PubMed Web of Science ®Google Scholar
• HarrisWSFish oils and plasma lipid and lipoprotein metabolism in humans: a critical reviewJ Lipid Res1989307858072677200
   PubMed Web of Science ®Google Scholar
• OuJTuHShanBUnsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXRProc Natl Acad Sci U S A2001986027603211371634
   PubMed Web of Science ®Google Scholar
• HannahVCOuJLuongAGoldsteinJLBrownMSUnsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cellsJ Biol Chem20012764365437211085986
   PubMed Web of Science ®Google Scholar
• BilzSSamuelVMorinoKSavageDChoiCSShulmanGIActivation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamstersAm J Physiol Endocrinol Metab2006290E716E72216291572
   PubMed Web of Science ®Google Scholar
• WatanabeMHoutenSMWangLBile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1cJ Clin Invest20041131408141815146238
   PubMed Web of Science ®Google Scholar
• ZhaoAYuJLewJLHuangLWrightSDCuiJPolyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targetsDNA Cell Biol20042351952615307955
   PubMed Web of Science ®Google Scholar
• KreyGBraissantOL’HorsetFFatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assayMol Endocrinol1997117797919171241
   PubMed Web of Science ®Google Scholar
• HertzRSheenaVKalderonBBermanIBar-TanaJSuppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferatorsBiochem Pharmacol2001611057106211301038
   PubMed Web of Science ®Google Scholar
• BergeRKMadsenLVaagenesHTronstadKJGottlicherMRustanACIn contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidationBiochem J1999343Pt 119119710493929
   PubMedGoogle Scholar
• Skulas-RayACWestSGDavidsonMHKris-EthertonPMOmega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemiaExpert Opin Pharmacother200891237124818422480
   PubMed Web of Science ®Google Scholar
• BaysHClinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acidsAm J Cardiol20069871i76i
   PubMed Web of Science ®Google Scholar
• WestphalSOrthMAmbroschAOsmundsenKLuleyCPostprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acidsAm J Clin Nutr20007191492010731497
   PubMed Web of Science ®Google Scholar
• JacobsonTAGlicksteinSBRoweJDSoniPNEffects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a reviewJ Clin Lipidol2012651822264569
   PubMed Web of Science ®Google Scholar
• ChanDCWattsGFBarrettPHBeilinLJRedgraveTGMoriTARegulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemiaDiabetes2002512377238612145148
   PubMed Web of Science ®Google Scholar
• BaysHEBallantyneCMKasteleinJJIsaacsohnJLBraeckmanRASoniPNEicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial)Am J Cardiol201110868269021683321
   PubMed Web of Science ®Google Scholar
• BallantyneCMBaysHEKasteleinJJEfficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study)Am J Cardiol201211098499222819432
   PubMed Web of Science ®Google Scholar
• YokoyamaMOrigasaHMatsuzakiMEffects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisLancet20073691090109817398308
   PubMed Web of Science ®Google Scholar
• SaitoYYokoyamaMOrigasaHEffects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)Atherosclerosis200820013514018667204
   PubMed Web of Science ®Google Scholar